| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | €8,6980 | -0,08 % | €156,10M | €5,275 | |
BRR ProCap Financial, Inc. Common Stock | €1,6487 | -5,78 % | €156,04M | €304,16K | |
HUMA Humacyte, Inc. Common Stock | €0,56803 | +0,22 % | €155,58M | €1,61M | |
HTLM HomesToLife Ltd Ordinary Shares | €1,6443 | -4,59 % | €155,35M | €14,61K | |
| €47,9078 | -1,40 % | €155,17M | €9,01K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | €14,7327 | -0,56 % | €155,02M | €6,46K | |
PAAC Proem Acquisition Corp I Ordinary Shares | €8,7534 | -0,05 % | €154,90M | €94,08 | |
BNR Burning Rock Biotech Limited American Depositary Shares | €8,1854 | +1,85 % | €154,86M | €4,08K | |
LFCR Lifecore Biomedical, Inc. Common Stock | €3,9437 | -2,07 % | €154,68M | €28,60K | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | €8,9601 | +0,00 % | €154,32M | €6,155 | |
| €3,4249 | -5,69 % | €154,21M | €55,51K | |
ECBK ECB Bancorp, Inc. Common Stock | €17,6871 | +1,28 % | €154,02M | €2,48K | |
TNXP Tonix Pharmaceuticals Holding Corp. | €9,2239 | -0,94 % | €153,90M | €150,01K | |
| €8,0104 | -1,62 % | €153,78M | €82,42K | |
DHF BNY Mellon High Yield Strategies Fund | €2,0883 | -1,04 % | €153,49M | €201,15K | |
